Tisdale MJ - Search Results

1

New cachexic factors.

Tisdale MJ. Tisdale MJ. Curr Opin Clin Nutr Metab Care. 1998 May;1(3):253-6. doi: 10.1097/00075197-199805000-00003. Curr Opin Clin Nutr Metab Care. 1998. PMID: 10565357 Review.

2

Zinc-alpha2-glycoprotein in cachexia and obesity.

Tisdale MJ. Tisdale MJ. Curr Opin Support Palliat Care. 2009 Dec;3(4):288-93. doi: 10.1097/SPC.0b013e328331c897. Curr Opin Support Palliat Care. 2009. PMID: 19823091 Review.

3

Clinical anticachexia treatments.

Tisdale MJ. Tisdale MJ. Nutr Clin Pract. 2006 Apr;21(2):168-74. doi: 10.1177/0115426506021002168. Nutr Clin Pract. 2006. PMID: 16556927 Review.

4

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.

Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD. Fearon KC, et al. Among authors: tisdale mj. J Clin Oncol. 2006 Jul 20;24(21):3401-7. doi: 10.1200/JCO.2005.04.5724. J Clin Oncol. 2006. PMID: 16849754 Clinical Trial.

5

Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.

Mirza KA, Pereira SL, Voss AC, Tisdale MJ. Mirza KA, et al. Among authors: tisdale mj. Nutrition. 2014 Jul-Aug;30(7-8):807-13. doi: 10.1016/j.nut.2013.11.012. Epub 2013 Dec 4. Nutrition. 2014. PMID: 24984997

6

Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition.

Eley HL, McDonald PS, Russell ST, Tisdale MJ. Eley HL, et al. Among authors: tisdale mj. Cancer Chemother Pharmacol. 2009 Mar;63(4):651-9. doi: 10.1007/s00280-008-0782-y. Epub 2008 Jun 14. Cancer Chemother Pharmacol. 2009. PMID: 18553083

7

Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle.

Todorov PT, Wyke SM, Tisdale MJ. Todorov PT, et al. Among authors: tisdale mj. Cancer Res. 2007 Dec 1;67(23):11419-27. doi: 10.1158/0008-5472.CAN-07-2602. Cancer Res. 2007. PMID: 18056470

8

Angiotensin II directly inhibits protein synthesis in murine myotubes.

Russell ST, Sanders PM, Tisdale MJ. Russell ST, et al. Among authors: tisdale mj. Cancer Lett. 2006 Jan 18;231(2):290-4. doi: 10.1016/j.canlet.2005.02.007. Cancer Lett. 2006. PMID: 16399230

9

Mechanism of induction of muscle protein degradation by angiotensin II.

Russell ST, Wyke SM, Tisdale MJ. Russell ST, et al. Among authors: tisdale mj. Cell Signal. 2006 Jul;18(7):1087-96. doi: 10.1016/j.cellsig.2005.09.009. Epub 2005 Oct 27. Cell Signal. 2006. PMID: 16257180

10

The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.

Tisdale MJ. Tisdale MJ. J Support Oncol. 2005 May-Jun;3(3):209-17. J Support Oncol. 2005. PMID: 15915823 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results